Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01053325Phase 3Completed
Phase 3, randomised, open-label trial of trimethoprim + sulfamethoxazole in malaria (5 arms), sponsored by Institute of Tropical Medicine Antwerp. Primary endpoint: Birth weight at delivery. Started Sep 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01053325.